Innovating with purpose.
The history of endoscopic retrograde cholangiopancreatography (ERCP) dates back to the 1960s when it was first introduced as a diagnostic procedure for examining the pancreatic and biliary ducts. Over the decades, this practice has evolved significantly with advancements in technology, making it possible to not only diagnose but also treat a variety of gastrointestinal conditions. Today, ERCP is a critical procedure that combines endoscopy and fluoroscopy to provide a minimally invasive approach to managing complex biliary and pancreatic diseases.
Boston Scientific’s ERCP portfolio embodies the Boston Scientific commitment to transforming lives through medical technology and solutions. With a focus on innovation, Boston Scientific aims to develop tools that are integral to the ERCP suite.